Autopsy report · NCT05244915
A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
Cause of deathSlow enrollment
“Study has been closed to accrual earlier than anticipated and will not resume.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 1 year 8 months before it stopped.
- 73 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University of Rochester
- Sponsor type
- University, hospital or other
- Conditions
- Cancer
- Interventions
- Experimental (Delphi Surveys); Experimental (Focus Groups); Qualitative interviews
- Participants
- 73
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
“Study was closed to low accrual.” - High Dose Rate Brachyablation of Primary Liver Lesions
“Study was closed due to poor accrual” - Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders
“Study closed before total enrollment met.” - A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
“Study closed to enrollment due to low accrual.” - Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
“accrual was slow and sporadic so the study was closed”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.